Newly diagnosed
Pathway Guide
Living with Ovarian Cancer
Stories
Glossary
Resources

PARP inhibitor

Definition:

Medications that target the chemical pathways cancer cells use to repair themselves.

The digital patient pathway was co-developed by the European Society of Gynaecological Oncology (ESGO), the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe), and AstraZeneca with funding provided by AstraZeneca.

Job code: Z4-68713 | Date of Preparation: September 2024

Job code: Z4-68713 Date of Preparation: September 2024

© 2024ESGO, ENGAGe, AstraZeneca. All Rights Reserved.

Privacy Policy
Terms of Use
Data protection principles